Supratherapeutic anticoagulation from low-molecular-weight heparin in lung transplant recipients

Standard dosing of enoxaparin in lung transplant recipients is associated with a high incidence of supratherapeutic anti-Xa levels. Further study will be required to correlate this finding with risk of hemorrhage.